It’s no secret that Boston, Massachusetts is home to many of the most groundbreaking advancements in medical discovery. That’s why yesterday, PhRMA sponsored its first national health care dialogue series focusing on the new era of medicine. The event, convened by The Atlantic, titled, “Through the Microscope: Examining Modern Medicine,” explored the transformation of patient care and the science that has revolutionized medical breakthroughs, new treatments and technologies, as well as the investments needed for future innovation.
Notable speakers included PhRMA president and CEO Stephen J. Ubl, biopharmaceutical research leaders Daniel Skovronsky of Eli Lilly and Company, Gilmore O’Neill of Biogen and Dana Farber Cancer Institute’s president and CEO Laurie Glimcher, MD.
Click here to watch the full video and learn more at GoBoldly.com
View Photos from The Event
Andrew Powaleny is Director of Public Affairs at PhRMA and leads the organizations scientific communications. Before joining PhRMA in 2015, he worked in public affairs for a small firm in Washington, DC and served as Deputy Press Secretary for the House Committee on Energy and Commerce. Andrew came to Washington, D.C. via Connecticut with a degree from Eastern Connecticut State University where he majored in public policy and government. Andrew is active as a runner and volunteer with the DC Front Runners; most recently serving on its Board of Directors for three years as co-race director. He is also a member of the NLGJA: The Association of LGBTQ Journalists and mentors students through his alumni association with The Fund for American Studies. Andrew is passionate about scientific innovation, especially for mental illness, and his heroes are the men and women of America’s biopharmaceutical research companies.